Search Results

Filter
  • 1-10 of  171,865 results for ""CARDIAC hypertrophy""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cardiac hypertrophy that affects hyperthyroidism occurs independently of the NLRP3 inflammasome.

  • Authors : Parletta AC; Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes, 2415, Butanta, Sao Paulo, 05508-000, Brazil.; Cerri GC

Subjects: NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism ; Hyperthyroidism*/Hyperthyroidism*/Hyperthyroidism*/metabolism ; Hyperthyroidism*/Hyperthyroidism*/Hyperthyroidism*/complications

  • Source: Pflugers Archiv : European journal of physiology [Pflugers Arch] 2024 Jul; Vol. 476 (7), pp. 1065-1075. Date of Electronic Publication: 2024 Apr 29.Publisher: Springer Country of Publication: Germany NLM ID: 0154720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-2013

Record details

×
Academic Journal

Mitochondria and NLRP3 inflammasome in cardiac hypertrophy.

  • Authors : Yan R; Department of Pathophysiology, Prostate Diseases Prevention and Treatment Research Center, College of Basic Medical Sciences, Jilin University, NO.990 Qinghua Street, Changchun, Jilin, China.; Department of Pathology, Zhuzhou Central Hospital, Zhuzhou, Hunan, China.

Subjects: NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/NLR Family, Pyrin Domain-Containing 3 Protein*/metabolism ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/metabolism ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/pathology

  • Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2024 Jul; Vol. 479 (7), pp. 1571-1582. Date of Electronic Publication: 2023 Aug 17.Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression.

  • Authors : Nie X; Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.; Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, 430030, China.

Subjects: Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/genetics ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/metabolism ; GTP Phosphohydrolases*/GTP Phosphohydrolases*/GTP Phosphohydrolases*/genetics

  • Source: Frontiers of medicine [Front Med] 2024 Jun; Vol. 18 (3), pp. 484-498. Date of Electronic Publication: 2024 May 14.Publisher: Higher Education Press Country of Publication: China NLM ID: 101549428 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure].

  • Authors : Barthou A; Université Paris-Saclay, Inserm UMR-S 1180, Orsay, France.; Kamel R

Subjects: Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Phosphodiesterase Inhibitors*/Phosphodiesterase Inhibitors*/Phosphodiesterase Inhibitors*/therapeutic use

  • Source: Medecine sciences : M/S [Med Sci (Paris)] 2024 Jun-Jul; Vol. 40 (6-7), pp. 534-543. Date of Electronic Publication: 2024 Jul 08.Publisher: EDK Country of Publication: France NLM ID: 8710980 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1958-5381

Record details

×
Academic Journal

Compound 3K attenuates isoproterenol-induced cardiac hypertrophy by inhibiting pyruvate kinase M2 (PKM2) pathway.

  • Authors : Rihan M; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar (Mohali) 160062, Punjab, India.; Sharma SS

Subjects: Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/chemically induced ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/drug therapy ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/prevention & control

  • Source: Life sciences [Life Sci] 2024 Aug 15; Vol. 351, pp. 122837. Date of Electronic Publication: 2024 Jun 13.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Artesunate attenuates isoprenaline induced cardiac hypertrophy in rats via SIRT1 inhibiting NF-κB activation.

  • Authors : Golatkar V; Department of Pharmacology, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai, India.; Bhatt LK

Subjects: Artesunate*/Artesunate*/Artesunate*/pharmacology ; Artesunate*/Artesunate*/Artesunate*/therapeutic use ; Sirtuin 1*/Sirtuin 1*/Sirtuin 1*/metabolism

  • Source: European journal of pharmacology [Eur J Pharmacol] 2024 Aug 15; Vol. 977, pp. 176709. Date of Electronic Publication: 2024 Jun 04.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Up-regulation of BRD4 contributes to gestational diabetes mellitus-induced cardiac hypertrophy in offspring by promoting mitochondria dysfunction in sex-independent manner.

  • Authors : Huang C; Department of Pharmacology, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, China.; Liu Z

Subjects: Diabetes, Gestational*/Diabetes, Gestational*/Diabetes, Gestational*/metabolism ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/metabolism ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/etiology

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2024 Aug; Vol. 226, pp. 116387. Date of Electronic Publication: 2024 Jun 27.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9-Mediated Splicing of NFATc4.

  • Authors : Yu S; State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, 150081, China.; Sun Z

Subjects: Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/genetics ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/metabolism ; Disease Models, Animal*

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Aug; Vol. 11 (29), pp. e2308769. Date of Electronic Publication: 2024 May 29.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

×
Academic Journal

Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1.

  • Authors : Liu S; School of Pharmaceutical Sciences, Sun Yat-Sen University, National and Local United Engineering Lab of Druggability and New Drugs Evaluation, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, China.; Su L

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Isoproterenol*/Isoproterenol*/Isoproterenol*/pharmacology

  • Source: Molecular and cellular endocrinology [Mol Cell Endocrinol] 2024 Aug 01; Vol. 589, pp. 112252. Date of Electronic Publication: 2024 Apr 20.Publisher: North Holland Publishing Country of Publication: Ireland NLM ID: 7500844 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Changes in cardiovascular arachidonic acid metabolism in experimental models of menopause and implications on postmenopausal cardiac hypertrophy.

  • Authors : Gerges SH; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; El-Kadi AOS

Subjects: Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/metabolism ; Cardiomegaly*/Cardiomegaly*/Cardiomegaly*/pathology ; Arachidonic Acid*/Arachidonic Acid*/Arachidonic Acid*/metabolism

  • Source: Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2024 Aug; Vol. 173, pp. 106851. Date of Electronic Publication: 2024 May 11.Publisher: Elsevier Science Country of Publication: United States NLM ID: 9808648 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  171,865 results for ""CARDIAC hypertrophy""